Guanfacine for Children with Tic Disorders
Conditions
Chronic Motor Tic Disorder | Chronic Vocal Tic Disorder | Tourette Syndrome
What is the purpose of this trial?
The Yale Child Study Center is recruiting subjects for a study of a new extended-release form of guanfacine (Intuniv®) in the treatment of tics in children with a Chronic Tic Disorder.
Participation Guidelines
- Age:
- 6 Years - 16 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Shire Pharmaceuticals
- Dates:
- March 2012 - September 2013
- Last Updated:
- Study HIC#:
- 1006004435
Clinicaltrials.gov ID: Yale6138683
For more information about this trial, contact:
Caitlin Tillberg
203-737-5317
caitlin.tillberg@yale.edu
Investigators
Lawrence Scahill,
Principal Investigator
Thomas Fernandez, MD
Principal Investigator
